Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Novo Nordisk A/S
NYSE:NVO
Novo Nordisk A/S
NYSE:NVO
Price:
39.13
USD
0.2%
Market Closed
Market Cap:
$174.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novo Nordisk A/S
NYSE:NVO
|
DK |
|
P
|
Pan American Silver Corp
F:PA2
|
CA |
|
J
|
Jeio Co Ltd
KOSDAQ:418550
|
KR |
Wall St Price Targets
NVO Price Forecast
Based on 31 analysts
Based on 31 analysts
+15% Upside
from
$39.13
today
Novo Nordisk A/S (NVO)’s 12-month stock price forecast through October 2027 has a consensus target of $45.06, implying 15% upside. The forecast is based on price targets from 31 Wall Street analysts.
NVO Analyst Rating
Based on 14 analysts
Based on 14 analysts
Analysts rate NVO Hold, with 10 of 14 recommending Hold.
Novo Nordisk A/S Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVO's stock price target?
Price Target
45.06
USD
45.06
USD
According to Wall Street analysts, the average 1-year price target for NVO is 45.06 USD with a low forecast of 30.6 USD and a high forecast of 69.74 USD.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
2%
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 2%.
What is the Gross Profit forecast for Novo Nordisk A/S?
Projected CAGR
2%
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
0%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 0%.
What is the Pre-Tax Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
0%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
-1%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is -1%.